Snowball logo
logo
0484

Hyundai Bioscience Co. Ltd

048410 KQ
8,040.00+90.00  (1.13%)
Estimate
Beta
0.862
Growth
Revenue, YoY
-54.19%
Net income, YoY
13.45%
FCF, YoY
51.85%
About the company
Ticker
048410
ISIN
KR7048410005
Country
South Korea
Sector (GICS)
Information Technology
Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.

Frequently asked questions

What sector does Hyundai Bioscience Co. Ltd (048410) operate in?

Hyundai Bioscience Co. Ltd belongs to the Information Technology sector and operates in the Biotechnology industry.

What is Hyundai Bioscience Co. Ltd (048410) current stock price?

As of the latest data, Hyundai Bioscience Co. Ltd stock price is ₩8,040, with a previous close of ₩7,950. Hyundai Bioscience Co. Ltd gained ₩90 in the last trading session, representing a 1.13% increase.

What is Hyundai Bioscience Co. Ltd (048410) current market capitalization?

Hyundai Bioscience Co. Ltd market cap is approximately 775.89 billion.

Does Hyundai Bioscience Co. Ltd (048410) pay dividends?

No. Hyundai Bioscience Co. Ltd does not pay a dividend.

What is Hyundai Bioscience Co. Ltd (048410) beta (volatility) score?

Hyundai Bioscience Co. Ltd has a beta of 0.862, meaning its volatility is roughly in line with the market.